In myeloma and other malignant lymphoid cell lines, studies have demonstrated that Notch1 is closely related to bone marrow stroma–mediated drug resistance, and that inhibition of Notch signalling sensitizes cells to chemotherapy and prevents bone marrow-mediated chemoresistance [36,37]. The gene discussed is NOTCH1; the disease is plasma cell myeloma.